Shionogi Gets New Oral COVID-19 Drug into Clinic in Less than 1 Year, Now Gearing Up for PII/III

Shionogi's Pharmaceutical Research Center Shionogi is developing an oral drug for COVID-19 at a pace that was unthinkable prior to the coronavirus pandemic. Other companies have repurposed molecules previously developed for other infections such as SARS and MARS, but Shionogi...read more